Announced

Completed

Lantheus completed the acquisition of Life Molecular Imaging from Life Healthcare for $780m.

Synopsis

Lantheus, a radiopharmaceutical-focused company, completed the acquisition of Life Molecular Imaging, a radiopharmaceutical company, from Life Healthcare, a private healthcare provider, for $780m. "This acquisition aligns with our strategy to drive long-term growth and value creation by investing in high-potential, complementary assets and R&D capabilities to strengthen our radiopharmaceutical leadership," Brian Markison, Lantheus CEO.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Lantheus completed the acquisition of Life Molecular Imaging from Life Healthcare for $780m.